Spielmann M, Toussaint C, Malcoste G, Le Chevalier T, Mondésir J M, Contesso G, Sarrazin D, Genin J, Rouesse J
Bull Cancer. 1985;72(3):202-9.
Breast sarcoma are rare, representing 1% of all malignant breast tumours. This is a retrospective study of 25 patients with a breast sarcoma, treated at Institut Gustave Roussy from 1954 to 1981. Thirty six per cent of these arose in a cystosarcoma phyllodes. A variety of histologies were found, the main one being malignant fibrohistiocytoma (44%). Nodal involvement was rare (4%) and, as in other sarcoma, hematogenous spread of metastases was more usual. Local recurrence occurred in 44% of cases and distant metastases (usually pulmonary) in 24%. The 3 year disease-free survival was 60% and the major prognostic factor was the mitotic index. Surgery is the treatment of choice of these tumours, supplemented by local irradiation in those cases where only a tumorectomy has been performed. The role of adjuvant chemotherapy remains undefined.
乳腺肉瘤较为罕见,占所有乳腺恶性肿瘤的1%。这是一项对1954年至1981年在古斯塔夫·鲁西研究所接受治疗的25例乳腺肉瘤患者的回顾性研究。其中36%起源于叶状囊肉瘤。发现了多种组织学类型,主要类型是恶性纤维组织细胞瘤(44%)。淋巴结受累罕见(4%),与其他肉瘤一样,血行转移更为常见。44%的病例出现局部复发,24%出现远处转移(通常为肺转移)。3年无病生存率为60%,主要预后因素是有丝分裂指数。手术是这些肿瘤的首选治疗方法,对于仅行肿瘤切除术的病例,辅以局部放疗。辅助化疗的作用仍不明确。